Patient Characteristics and association of Frailty
| All (n=29) n (%) | Min | Max | ||
| Mean Age (years) | 80 | 66 | 92 | |
| Males | 22 (76) | |||
| Ethnicity | Caucasian | 22 (76) | ||
| Asian | 3 (10) | |||
| Afro-Caribbean | 2 (7) | |||
| Other | 2 (7) | |||
| Body Mass Index (kg/m2) mean. | 25 | 17 | 36 | |
| FVC % predicted mean. | 90 | 49 | 146 | |
| TLCO % predicted mean. | 46 | 11 | 89 | |
| Oxygen saturations (%), At rest on room air, mean. | 96 | 92 | 98 | |
| On Oxygen | 3 | |||
| Antifibrotics | Not on Antifibrotics | 12 (41) | ||
| Nintedanib | 13 (45) | |||
| Pirfenidone | 4 (14) | |||
| Clinical Frailty Scale (CFS) mean. | 5 | 3 | 6 | |
| CFS score | four or under 0 | 11 | ||
| 5 (mild frailty) | 8 | |||
| 6 (moderate frailty) | 10 | |||
| 7 + (severe frailty) | 0 | |||
| GAP score | 1–3 stage I | 10 (35) | ||
| 4–5 stage II | 12 (41) | |||
| 6–8 stage III | 5 (17) | |||
| Missing data | 2 (7) | |||
Clinical Frailty Scale (CFS) Minimum 1, not frail; Maximum 9, most frail, terminally ill GAP score using (GAPscore). gender, age and physiology, comprising FVC % and DLCO % It identifies three stages of severity: a 1-year mortality risk of 6%, 16% and 39% respectively (Ley et al., (2012).